BLUEJET

Blue Jet Healthcare Limited

Specialty-chemistry and CDMO services for pharma intermediates and contrast media

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

bluejethealthcare.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹520.65
Market cap
9,855 Cr
Stock P/E
38.5
P/B
6.64
Dividend yield
0.2%
ROE (FY21)
40.7%
ROCE (FY21)
48.5%
Operating margin (FY21)
37.4%
Debt / equity (FY21)
0.15
OCF / EBITDA (FY26)
113.6%
OCF / EBITDA (3Y)
68.9%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Blue Jet Healthcare is an Indian contract development and manufacturing (CDMO) company that makes contrast-media intermediates, pharmaceutical intermediates and active ingredients (PI/API) and high-intensity sweeteners for global pharma customers.

Company snapshot

44thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Net margin of 27.2% — the business keeps a healthy share of every rupee it earns.
3 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales181 Cr167 Cr184 Cr163 Cr208 Cr318 Cr340 Cr355 Cr165 Cr192 Cr235 Cr293 Cr
Operating expenses (approx.)119 Cr112 Cr131 Cr119 Cr139 Cr194 Cr200 Cr234 Cr111 Cr146 Cr163 Cr195 Cr
EBITDA63 Cr55 Cr53 Cr44 Cr69 Cr124 Cr140 Cr121 Cr55 Cr47 Cr71 Cr98 Cr
OPM %34.5%32.7%28.8%27.2%33.4%39.0%41.1%34.1%33.2%24.4%30.4%33.5%
Other income8 Cr7 Cr9 Cr9 Cr12 Cr13 Cr12 Cr8 Cr24 Cr13 Cr23 Cr15 Cr
Interest0.04 Cr0.04 Cr0.03 Cr0.03 Cr0.02 Cr0.02 Cr0.03 Cr0.69 Cr5 Cr0.34 Cr0.58 Cr0.66 Cr
Depreciation6 Cr8 Cr8 Cr3 Cr5 Cr5 Cr5 Cr6 Cr6 Cr6 Cr6 Cr7 Cr
Profit before tax64 Cr44 Cr54 Cr49 Cr77 Cr132 Cr147 Cr123 Cr69 Cr54 Cr87 Cr106 Cr
Tax %25.6%26.5%26.8%23.6%24.1%25.3%25.2%25.8%24.1%25.3%26.2%26.1%
Net profit48 Cr32 Cr39 Cr38 Cr58 Cr99 Cr110 Cr91 Cr52 Cr40 Cr64 Cr78 Cr
EPS (₹)₹2.76₹1.85₹2.29₹2.18₹3.36₹5.71₹6.35₹5.26₹3.01₹2.32₹3.71₹4.51

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales683 Cr721 Cr712 Cr1,030 Cr947 CrSign in free for the trailing twelve months
Operating expenses (approx.)434 Cr502 Cr482 Cr652 Cr653 CrSign in free for the trailing twelve months
EBITDA249 Cr219 Cr229 Cr378 Cr294 CrSign in free for the trailing twelve months
OPM %36.5%30.4%32.2%36.7%31.0%Sign in free for the trailing twelve months
Other income19 Cr24 Cr29 Cr46 Cr69 CrSign in free for the trailing twelve months
Interest3 Cr1 Cr0.16 Cr0.10 Cr6 CrSign in free for the trailing twelve months
Depreciation22 Cr25 Cr28 Cr18 Cr24 CrSign in free for the trailing twelve months
Profit before tax243 Cr217 Cr220 Cr406 Cr333 CrSign in free for the trailing twelve months
Tax %25.3%26.1%25.6%24.8%25.5%Sign in free for the trailing twelve months
Net profit182 Cr160 Cr164 Cr305 Cr248 CrSign in free for the trailing twelve months
EPS (₹)₹10.47₹9.23₹9.44₹17.59₹14.29Sign in free for the trailing twelve months
Dividend payout %——0.0%5.7%8.4%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital35 Cr35 Cr35 Cr35 Cr35 Cr
Reserves487 Cr647 Cr811 Cr1,098 Cr1,325 Cr
Borrowings—————
Other liabilities192 Cr181 Cr214 Cr284 Cr281 Cr
Total liabilities713 Cr862 Cr1,059 Cr1,418 Cr1,641 Cr
Fixed assets (net)118 Cr128 Cr172 Cr260 Cr314 Cr
CWIP3 Cr30 Cr147 Cr89 Cr301 Cr
Investments94 Cr189 Cr250 Cr187 Cr252 Cr
Inventories105 Cr126 Cr130 Cr264 Cr187 Cr
Trade receivables227 Cr239 Cr177 Cr350 Cr339 Cr
Cash & bank75 Cr65 Cr41 Cr33 Cr61 Cr
Other assets90 Cr84 Cr142 Cr236 Cr186 Cr
Total assets713 Cr862 Cr1,059 Cr1,418 Cr1,641 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity146 Cr142 Cr241 Cr46 Cr334 Cr
Cash from investing-76 Cr-147 Cr-264 Cr-35 Cr-276 Cr
Cash from financing-56 Cr-4 Cr-2 Cr-19 Cr-31 Cr
Net cash flow14 Cr-10 Cr-24 Cr-8 Cr28 Cr
Free cash flow (OCF − Capex)125 Cr82 Cr68 Cr-34 Cr334 Cr

Ratios

MetricMar 2021
ROCE %48.5%
ROE %40.7%
Debtor days105
Inventory days200
Days payable101
Cash conversion cycle204
OCF / EBITDA %62.7%
Debt / equity0.15
Current ratio2.39
Net debt / EBITDA-0.05